NCT07068906View on ClinicalTrials.gov

A Clinical Study Exploring CT1194C in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 15, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2027

Conditions
B-Cell Non-Hodgkin Lymphoma
Interventions
DRUG

CAR-T cells chimenric antigen receptor T cells

CT1194C cells infusion

Trial Locations (1)

300020

China Institute of Hematology and Blood Diseases Hospital, Tianjin

All Listed Sponsors
lead

Institute of Hematology & Blood Diseases Hospital, China

OTHER